Methodology

All entries for: Affinia Therapeutics

July 16, 2026

Affinia Therapeutics

Orphan Drug Designation

treatment of dilated cardiomyopathy due to mutations in the BAG3 gene

Disease Area: Rare Diseases
Source
Scroll to Top